EHA2025 Sponsored session: Vertex Pharmaceuticals: The patient journey in sickle cell disease (SCD) and transfusion-dependent ß-thalassaemia (TDT) – How can we transform the road ahead with gene therapy?

EHA Library, Faculty / Presenters, 4183285

EHA2025 Sponsored Session: ALEXION: Recognizing optimal outcomes for Patients with Paroxysmal Nocturnal Haemoglobinuria (PNH)

EHA Library, Faculty / Presenters, 4183274

EHA2025 Sponsored Session: JOHNSON & JOHNSON: Staying CURE-ious: translating multiple myeloma guidelines into clinical practice

EHA Library, Faculty / Presenters, 4183273

EHA2025 Sponsored Session: ALEXION: Not as Rare as You Think - Hidden Light Chain Amyloidosis in your Myeloma Clinic

EHA Library, Faculty / Presenters, 4183272

EHA2025 Sponsored Session: JONHSON & JOHNSON: Leveraging efficacy, balancing safety: Multi-dimensional decision-making in the fixed duration therapy (FDT) era of chronic lymphocytic leukeamia (CLL)

EHA Library, Faculty / Presenters, 4183271

EHA2025 Sponsored Session: MENARINI STEMLINE: Innovating relapsed refractory multiple myeloma care: Unmet needs, therapy management, and real-world experience

EHA Library, Faculty / Presenters, 4183270

EHA2025 Sponsored Session: PHYSICIANS' EDUCATION RESOURCE: Medical Crossfire™: Expert Perspectives on Applying Recent Evidence to Practice in the Management of Newly Diagnosed Multiple Myeloma

EHA Library, Faculty / Presenters, 4183269

EHA2025 sponsored Session: JOHNSON & JOHNSON: Staying CURE-ious: is there a road to cure in 2025 and beyond?

EHA Library, Faculty / Presenters, 4183268

EHA2025 Sponsored Session: AMGEN: Frontline therapy of B-cell acute lymphoblastic leukemia (B-ALL): harnessing innovative approaches to improve outcomes

EHA Library, Faculty / Presenters, 4183267

Test

EHA Library, Faculty / Presenters, 4177687

UPDATED EFFICACY AND SAFETY OF THE BRUTON TYROSINE KINASE (BTK) DEGRADER BGB-16673 IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) CLL/SLL: RESULTS FROM THE ONGOING PHASE (PH) 1 CADANCE-101 STUDY

EHA Library, Lydia Scarfò, 4159235

UPDATED RESULTS FROM THE PHASE 1 STUDY OF SONROTOCLAX (BGB-11417), A NOVEL BCL2 INHIBITOR, IN COMBINATION WITH ZANUBRUTINIB FOR RELAPSED/REFRACTORY CLL/SLL DEMONSTRATE DEEP AND DURABLE RESPONSES

EHA Library, Chan Y. Cheah, 4159236

EFFICACY AND SAFETY OF AZACITIDINE IN VEXAS SYNDROME:LARGE SCALE STUDY FROM THE FRENVEX

EHA Library, Thibault Comont, 4159252

A DECISION SUPPORT SYSTEM FOR PERSONALIZED OPTIMIZATION OF HEMATOPOIETIC STEM CELL TRANSPLANTATION TIMING IN CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Matteo Giovanni Della Porta, 4159253

MINIMAL RESIDUAL DISEASE-DRIVEN STRATEGY FOLLOWING ISATUXIMAB-CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE INDUCTION IN TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: PRIMARY ENDPOINTS OF THE PHASE 3 MIDAS TRIAL

EHA Library, Aurore Perrot, 4159282

A RANDOMIZED, MULTI-CENTER STUDY OF CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE (KRD) WITH OR WITHOUT DARATUMUMAB (D) FOR THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): THE ADVANCE CLINICAL TRIAL

EHA Library, C. Ola Landgren, 4159284

INCA035784, A NOVEL, EQUIPOTENT T CELL-REDIRECTING ANTIBODY FOR PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS CARRYING DIFFERENT TYPES OF CALRETICULIN MUTATIONS

EHA Library, Beth Psaila, 4159289

SPATIAL TRANSCRIPTOMIC ANALYSIS IDENTIFIES NOVEL MICROENVIRONMENTAL IMMUNE SIGNATURES AND STROMAL REMODELLING ASSOCIATED WITH FIBROSIS IN MYELOPROLIFERATIVE NEOPLASIA

EHA Library, Rosalin Cooper, 4159291

FRONTLINE PHASE II RITUXIMAB-POLATUZUMAB-GLOFITMAB (R-POLA-GLO) TRIAL DEMONSTRATES A MANAGEABLE SAFETY PROFILE AND HIGH RESPONSE RATES IN ELDERLY AND MEDICAL UNFIT PATIENTS WITH AGGRESSIVE LYMPHOMA

EHA Library, Thomas Melchardt, 4159325

EXCELLENT OUTCOME WITH INTERIM PET ADAPTED TREATMENT REDUCTION IN ELDERLY DLBCL PTS WITH FAVOURABLE PROGNOSIS: RESULTS OF 288 PTS TREATED IN OPTIMAL>60 TRIAL OF THE DSHNHL/GLA

EHA Library, Viola Pöschel, 4159326

LOW RATES OF HIGH-GRADE TOXICITIES WITH GLPG5101, A FRESH, STEM-LIKE, EARLY MEMORY PHENOTYPE ANTI-CD19 CAR T-CELL THERAPY IN PATIENTS WITH NON-HODGKIN LYMPHOMA IN THE ATALANTA-1 STUDY

EHA Library, Pim Mutsaers, 4159358

CTD402: A UNIVERSAL ANTI-CD7 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR PATIENTS WITH RELAPSED OR REFRACTORY (R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL)

EHA Library, Jiangtao Ren, 4159360

PREDICTORS AND OUTCOMES FOR IMMUNE EFFECTOR CELL ASSOCIATED DELAYED NEUROTOXICITIES IN MULTIPLE MYELOMA PATIENTS RECEIVING CILTA-CEL: A REAL WORLD ANALYSIS FROM THREE US CENTERS

EHA Library, Kenneth Jin Chang Lim, 4159361

EFFICACY AND SAFETY OF BRL-101 IN TDT AND SCD

EHA Library, Tan Qian, 4159367

FIRST-IN-HUMAN STUDY OF AUTOLOGOUS HBA2-EDITED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS IN ALPHA-THALASSEMIA WITH CONSTANT SPRING MUTATION

EHA Library, Hui Xu, 4159369

INTRACELLULAR IRON OVERLOAD AND DEFECTIVE STROMAL NICHE IMPAIR HEMATOPOIETIC STEM CELLS IN SICKLE CELL DISEASE

EHA Library, Silvia Sighinolfi, 4159371

PHASE 3 LUNA3 STUDY: FIRST EFFICACY/SAFETY REPORT OF LONG-TERM EXTENSION PERIOD WITH RILZABRUTINIB IN ADULTS WITH PERSISTENT/CHRONIC IMMUNE THROMBOCYTOPENIA

EHA Library, Waleed Ghanima, 4159387

SHORT-TERM RESPONSE AND SAFETY OF DARATUMUMAB TREATMENT IN ADULT IMMUNE THROMBOCYTOPENIA: RESULTS OF A PHASE II STUDY WITH SAFETY RUN-IN (THE DART STUDY)

EHA Library, Galina Tsykunova, 4159388

HLA PROFILE IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: COMPARISON WITH HEALTHY INDIVIDUALS AND PROGNOSTIC IMPLICATIONS

EHA Library, Yessenia Lizbeth Molina Cabrera, 4159391

CLINICAL VALIDATION STUDY OF AN AI SYSTEM FOR BONE MARROW CELL CLASSIFICATION AND DYSPLASIA DETECTION

EHA Library, David Bermejo-Peláez, 4159410

REFINEMENT AND INTERNATIONAL VALIDATION OF A MACHINE LEARNING ALGORITHM FOR CLASSIFYING ACUTE LEUKEMIA SUBTYPES USING ROUTINE LABORATORY DATA

EHA Library, Merlin Engelke, 4159411

ADDITION OF BLINATUMOMAB TO CONSOLIDATION THERAPY FOR YOUNGER ADULTS (BCR:ABL1-NEGATIVE B-ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) ON THE ECOG-ACRIN E1910 PHASE III TRIAL

EHA Library, Shira Dinner, 4159187

HETEROGENEOUS TRANSCRIPTION FACTOR AND SUPER-ENHANCER DYSREGULATION IN AML REVEALED BY INTEGRATED CHROMATIN PROFILING

EHA Library, Yotaro Ochi, 4159210

THE COMBINATION OF A FLT3-ITD, NPM1MUT AND AN EPIGENETIC REGULATORY GENE MUTATION CONFERS UNIQUE SENSITIVITY TO QUIZARTINIB: ANALYSIS FROM THE QUANTUM-FIRST TRIAL

EHA Library, Mark Levis, 4159217

STEM CELL AGING CLOCK: A DEEP LEARNING DRIVEN FRAMEWORK FOR PREDICTING STEM CELL AGE

EHA Library, Guanlin Wang, 4159409

A FINE-TUNED FOUNDATION MODEL FOR DIGITAL PATHOLOGY IN MYELODYSPLASTIC SYNDROMES: ADVANCING PERSONALIZED MEDICINE

EHA Library, Gianluca Asti, 4159408

INTEGRATIVE MULTIDIMENSIONAL ANALYSIS OF IMMUNE SIGNATURES USING MULTI-OMICS DATA FOR PATIENT STRATIFICATION: A CASE STUDY ON MYELODYSPLASTIC SYNDROMES (MDS)

EHA Library, Ziying Zhang, 4159407

BARICITINIB CORRECTS AP2-NAK MEDIATED C-MPL ENDOCYTIC DYSREGULATION TO RESTORE MEGAKARYOCYTES TPO-RA SENSITIVITY IN IMMUNE THROMBOCYTOPENIA

EHA Library, Zhuo-Yu An, 4159390

A PHASE 2 STUDY OF IANALUMAB IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH AT LEAST TWO LINES OF THERAPY (VAYHIT3)

EHA Library, Charlotte Bradbury, 4159389

ATRIAL FIBRILLATION PREVALENCE AND ITS MANAGEMENT IN THE AGING TRANSFUSION-DEPENDENT BETA-THALASSEMIA

EHA Library, Valeria Di Stefano, 4159370

TREATMENT OF PATIENTS WITH SEVERE TRANSFUSION-DEPENDENT ß-THALASSEMIA WITH CS-101, AN AUTOLOGOUS, EX VIVO EDITED, CD34+ HEMATOPOIETIC STEM CELL PRODUCT USING INNOVATIVE TRANSFORMER BASE EDITOR (TBE)

EHA Library, Jia Chen, 4159368

CAR-T CELLS SPECIFIC TOXICITIES AS MAJOR DETERMINANTS OF NON-RELAPSE MORTALITY: AN ANALYSIS FROM THE ITALIAN CART-SIE STUDY

EHA Library, Angelica Barone, 4159359

ENHANCED CAR T-CELL EXPANSION AND DURABLE COMPLETE RESPONSES WITH NKTR-255 PLUS LISOCABTAGENE MARALEUCEL IN RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, Alexandre Hirayama, 4159357

DURABLE EFFICACY WITH FIXED-DURATION EPCORITAMAB + POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA-R-CHP) FOR 1L DIFFUSE LARGE B-CELL LYMPHOMA (EPCORE NHL-5)

EHA Library, Daniel Kerr, 4159324

A PIVOTAL STUDY OF SHR2554, AN ORAL INHIBITOR AGAINST ENHANCER OF ZESTE HOMOLOG 2 (EZH2), IN RELAPSED OR REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL)

EHA Library, Yuqin Song, 4159323

FIRST DISCLOSURE OF EPCORITAMAB + R-ICE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL) ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): EPCORE NHL-2

EHA Library, Raul Cordoba, 4159322

MUTATIONS IN SETBP1 DRIVE GRANULOCYTE LINEAGE OUTPUT AND LEUKEMOGENESIS VIA KAT7-MEDIATED EPIGENETIC MODULATION AND TRANSCRIPTIONAL REPROGRAMMING

EHA Library, Samantha Tauchmann, 4159290

FINAL ANALYSIS OF FIXED-DURATION IBRUTINIB + VENETOCLAX FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL) IN THE PHASE 2 CAPTIVATE STUDY

EHA Library, Paolo Ghia, 4159233

IBRUTINIB PLUS VENETOCLAX WITH MRD-GUIDED DURATION OF TREATMENT IS SUPERIOR TO BOTH CONTINUOUS IBRUTINIB MONOTHERAPY AND FCR FOR PREVIOUSLY UNTREATED CLL: REPORT OF THE PHASE III UK FLAIR STUDY

EHA Library, Talha Munir, 4159232

LONG-TERM FOLLOW-UP OF PREDOMINANTLY ASIAN PATIENTS WITH RELAPSED/REFRACTORY FLT3-MUTATED ACUTE MYELOID LEUKEMIA TREATED WITH GILTERITINIB VERSUS SALVAGE CHEMOTHERAPY IN THE PHASE 3 COMMODORE TRIAL

EHA Library, Jianxiang Wang, 4159220

INTRINSIC RNA RECEPTOR SIGNALING IN AML MODULATES 5'-AZACITIDINE EFFICACY AND CAN BE RE-SENSITIZED DURING ACQUIRED RESISTANCE BY ALL-TRANS RETINOIC ACID

EHA Library, Nadia El Khawanky, 4159209

SINGLE-CELL RNA AND ATAC-SEQ HIGHLIGHTS RAPID ADAPTATION OF MONOSOMY 7 PROGENITOR POPULATIONS TO NOVEL THERAPIES IN AML

EHA Library, Rachel Thijssen, 4159207

CAN CAR T-CELL THERAPY BE A DEFINITIVE TREATMENT FOR ADULT R/R B-ALL WITHOUT TRANSPLANT? LONG-TERM FINDINGS AND PREDICTORS OF SUSTAINED REMISSION FOR OBECABTAGENE AUTOLEUCEL

EHA Library, Jae H. Park, 4159190

SAFETY AND EFFICACY OF SINGLE-AGENT SUBCUTANEOUS BLINATUMOMAB IN ADULTS WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): RESULTS FROM A PHASE 1/2 DOSE EXPANSION STUDY

EHA Library, Elias Jabbour, 4159189

OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN STRATIFIED BY CUMULATIVE DOSE

EHA Library, Wendy Stock, 4159188

EFFICACY AND SAFETY OUTCOMES OF OBECABTAGENE AUTOLEUCEL (OBE-CEL) STRATIFIED BY AGE IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL)

EHA Library, Bijal D. Shah, 4159191

MECOM IS A MASTER REPRESSOR OF MYELOID DIFFERENTIATION THROUGH DOSE CONTROL OF CEBPA IN ACUTE MYELOID LEUKEMIA

EHA Library, Dorien Pastoors, 4159208

DE NOVO DESIGN OF A CHROMATIN READER ZMYND8-TARGETING PEPTIDE PROTAC FOR ACUTE MYELOID LEUKEMIA THERAPY

EHA Library, hui feng, 4159211

EFFICACY AND SAFETY OF PIVEKIMAB SUNIRINE (PVEK) IN PATIENTS (PTS) WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN) IN THE CADENZA STUDY

EHA Library, Naveen Pemmaraju, 4159218

PHASE I/II STUDY OF DECITABINE, VENETOCLAX, AND QUIZARTINIB TRIPLET COMBINATION IN FLT3-ITD MUTATED AML

EHA Library, Musa Yilmaz, 4159219

A CD33-DELETED ALLOGRAFT (TREM-CEL) ENABLES GEMTUZUMAB OZOGAMICIN MAINTENANCE POST-HEMATOPOIETIC CELL TRANSPLANT WITH THERAPEUTIC EXPOSURES AND LOW TOXICITY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Guenther Koehne, 4159221

IMPACT OF VENETOCLAX-BASED THERAPIES ON AUTOIMMUNE CYTOPENIAS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: FINAL ANALYSIS OF A MULTICENTER STUDY CONDUCTED BY ERIC

EHA Library, Candida Vitale, 4159234

OVERALL SURVIVAL AND DURATION OF TRANSFUSION INDEPENDENCE FOR FIRST-LINE ESA-NAIVE PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES TREATED WITH LUSPATERCEPT VS EPOETIN ALFA IN THE COMMANDS TRIAL

EHA Library, Valeria Santini, 4159254

EFFICACY OF MACROPHAGE CHECKPOINT CLEVER-1 INHIBITION WITH BEXMARILIMAB PLUS AZACITIDINE IN MYELODYSPLASTIC SYNDROME: RESULTS FROM THE PH1/2 BEXMAB STUDY

EHA Library, Mika Kontro, 4159255

DURABLE RESPONSES TO LENZILUMAB - AZACITIDINE COMBINATION THERAPY IN HIGH RISK PROLIFERATIVE CMML WITH SUPPRESSION OF CBL AND RAS MUTANT SUBCLONES

EHA Library, Daniel Thomas, 4159256

ELRANATAMAB IN COMBINATION WITH DARATUMUMAB AND LENALIDOMIDE (EDR) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) NOT ELIGIBLE FOR TRANSPLANT: INITIAL RESULTS FROM MAGNETISMM-6 PART 1

EHA Library, Meletios Dimopoulos, 4159283

ANALYSIS OF SUSTAINED MRD NEGATIVITY IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE WITH OR WITHOUT ISATUXIMAB (PHASE III ISKIA TRIAL)

EHA Library, Francesca Gay, 4159285

ISATUXIMAB, CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (ISA-KRD) FOR HIGH-RISK (HR) NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): FIRST-TIME REPORT OF THE FULL COHORT OF TRANSPLANT-ELIGIBLE (TE) PATIENTS IN THE GMMG-CONCEPT TRIAL

EHA Library, Lisa Leypoldt, 4159286

ROBUST MOUSE MODEL OF SECONDARY ACUTE MYELOID LEUKEMIA: REVEALING KEY ROLE OF TP53 MUTATIONS AND PERSISTENT STAT5 ACTIVATION.

EHA Library, Stefan N. Constantinescu, 4159287

DISCOVERY OF FIRST-IN-CLASS PRECISION ANTIBODY DRUG CONJUGATES TARGETING MUTANT CALRETICULIN FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS.

EHA Library, Norman Fultang, 4159288

PHASE 2 STUDY OF TALQUETAMAB + TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND EXTRAMEDULLARY DISEASE: REDIRECTT-1

EHA Library, Shaji Kumar, 4173809

INCA33989 IS A NOVEL, FIRST IN CLASS, MUTANT CALRETICULIN-SPECIFIC MONOCLONAL ANTIBODY THAT DEMONSTRATES SAFETY AND EFFICACY IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET)

EHA Library, John Mascarenhas, 4173810

TRANSCRIPTIONAL REPROGRAMMING AND SURVIVAL CO-DEPENDENCIES OF CHRONIC LYMPHOCYTIC LEUKEMIA RESISTANT TO VENETOCLAX

EHA Library, Daisy Diaz Rohena, 4173811

SAFETY AND EFFICACY OF CM313 IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: A RANDOMIZED, PLACEBO-CONTROLLED TRIAL

EHA Library, Yanmei Xu, 4173812

HCT FRAILTY SCALE (HCT-FS) FOR ASSESSING FRAILTY IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT PATIENTS. RESULTS FROM A MULTICENTER AND PROSPECTIVE CANADIAN AND SPANISH INITIATIVE

EHA Library, Maria Queralt Salas, 4173813

LONG-TERM OUTCOMES OF PEBL-ENGINEERED CD7 NANOBODY CAR-T (PA3-17 INJECTION) IN RELAPSED/REFRACTORY T-ALL/LBL: PHASE I TRIAL UPDATE

EHA Library, Meng Lv, 4160445

REAL-WORLD OUTCOMES OF ADULT B-ALL PATIENTS WHO EXPERIENCE RELAPSED OR REFRACTORY DISEASE FOLLOWING BREXUCABTAGENE AUTOLEUCEL, A STUDY BY THE ROCCA CONSORTIUM

EHA Library, Rawan Faramand, 4160444

EFFICACY AND SAFETY OF REGIMEN WITH OLVEREMBATINIB AND BLINATUMOMAB FOR THE FRONTLINE TREATMENT OF PH-POSITIVE OR PH-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Xiuli Xu, 4160443

LONG NON-CODING RNAS AND THEIR ROLE ON EPIGENOME AS DIAGNOSTIC MARKERS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA OF T CELLS

EHA Library, Giovanni Smaldone, 4160441

ROLE OF FRUCTOSE TRANSPORTER (GLUT5) EXPRESSION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Serene Xavier, 4160440

THERAPEUTIC EFFICACY OF BIOMIMETIC NANODRUG CX4945 IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Yan Wang, 4160432

INDUCTION OF ONTOGENY-SPECIFIC PRE-LEUKEMIC STEM CELLS IN A KMT2A::AFF1 MURINE MODEL

EHA Library, Ariana Calderón, 4160431

TARGETING ONCOGENE-INDUCED SENESCENCE IN ETV6::RUNX1 PRE-LEUKEMIC CELLS

EHA Library, Mayla Bertagna, 4160430

BCR::ABL1 BALANCES CELLULAR DEMAND AND SUPPLY BY JOINTLY ENGAGING STAT5 SIGNALING AND GLYCOLYTIC METABOLISM DOWNSTREAM OF INTERLEUKIN 7 RECEPTOR IN MURINE PREB CELLS

EHA Library, Dennis Das Gupta, 4160429

SMARCC1 CONTROLS THE ONCOGENIC NOTCH1 TRANSCRIPTIONAL PROGRAM IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Khalid Shoumariyeh, 4160427

CAPTURE PROFILING REVEALS AGE-RELATED IG/TR PROFILES, MUTATIONAL PATTERNS AND CLONAL HAEMATOPOIESIS SIGNATURES IN ADULT PATIENTS WITH ALL

EHA Library, Cecilia Bozzetti, 4160416

DEEP MOLECULAR PROFILING REVEALS PROGNOSTIC MARKERS FOR REFINED PATIENT STRATIFICATION AND TARGETABLE ALTERATIONS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Borbála Péterffy, 4160420

L-ASPARAGINASE ALTERS REDOX HOMEOSTASIS IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Matus Kolarik, 4160423

ROLE OF TP53 MUTATIONS IN REFINING PROGNOSIS OF KTM2A-REARRANGED ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

EHA Library, Mariangela Di Trani, 4160425

CD49F, A USEFUL MRD AND SUPPOSED PREDICTIVE MARKER OF LATE RELAPSE IN PEDIATRIC B-ALL

EHA Library, Gábor Barna, 4160428

CHEMORESISTANT ALL CELL LINES EXHIBIT REDUCED MITOCHONDRIAL DAMAGE AND INCREASED MITOCHONDRIAL BIOGENESIS UPON CHEMOTHERAPY.

EHA Library, Jenny Chatzigerou, 4160434

MUSASHI-2 PROMOTES CHEMOTHERAPY RESISTANCE OF INFANT KMT2A-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA VIA REGULATING THE BIOENERGETIC METABOLISM.

EHA Library, Luigia Valsecchi, 4160435

MOLECULAR DETERMINANTS OF SENSITIVITY AND RESISTANCE TO A NOVEL AKR1C3-ACTIVATED PRODRUG IN PEDIATRIC LEUKEMIA

EHA Library, Faezeh Khalili, 4160436

WHOLE TRANSCRIPTOME SEQUENCING UNCOVERS KEY CODING AND NON-CODING BIOMARKERS IN IKZF1PLUS B-ALL

EHA Library, Gadha Krishna Leons, 4160438

IDENTIFYING SYNERGISTIC ACTIVITIES OF COMBINED INHIBITION OF TYROSINE KINASES AND ANTI-APOPTOTIC MOLECULES IN ABL1 FUSION-POSITIVE ALL

EHA Library, Johanna Bender, 4160439

B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKAEMIA CAUSES PARACRINE SENESCENCE IN MESENCHYMAL STROMAL CELLS TO SUBVERT THE TREATMENT RESPONSE IN ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Aditi Dey, 4160442

LEUKEMIC STEM CELL SIGNATURES IMPROVE RISK STRATIFICATION IN T-ALL PATIENTS

EHA Library, YI WEI Lee, 4160446

NOTCH1 TRANSLOCATIONS DEFINE A SPECIFIC SUBTYPE OF HIGH-RISK CORTICAL TYPE T-CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

EHA Library, Martina Lucarelli, 4160426

CLUSTERING ANALYSIS OF ALTERNATIVE SPLICING IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IDENTIFIED TARGETABLE SUBTYPE WITH GLOBAL SPLICING DEFECTS

EHA Library, Margaret Heung-Ling Ng, 4160424

SENSITISATION AND ERADICATION OF DRUG-RESISTANT PAEDIATRIC ETP-ALL BY REPURPOSING DECITABINE

EHA Library, Yizhou Huang, 4160422